Lymphoid tumours and breast cancer in ataxia telangiectasia; Substantial protective effect of residual ATM kinase activity against childhood tumours

British Journal of Cancer

Volumn 105, Issue 4, 2011, Pages 586-591

  Reiman, A ^a   Srinivasan, V ^a   Barone, G ^a   Last, J I ^a   Wootton, L L ^a   Davies, E G ^b   Verhagen, M M ^c   Willemsen, M A ^c   Weemaes, C M ^c   Byrd, P J ^a   Izatt, L ^d   Easton, D F ^e   Thompson, D J ^e   Taylor, A M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Ataxia telangiectasia; ATM; ATM kinase; breast cancer; lymphoma

Indexed keywords

ATM PROTEIN;

ADOLESCENT; ADULT; AGE; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CHILDHOOD CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; LYMPHATIC SYSTEM TUMOR; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; UNITED KINGDOM;

ADOLESCENT; ADULT; ATAXIA TELANGIECTASIA; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CHILD; DNA-BINDING PROTEINS; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOBLOTTING; KAPLAN-MEIER ESTIMATE; LYMPHOMA; MALE; MUTATION; NEOPLASMS; NETHERLANDS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 80051591336     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.266     Document Type: Article

References (28)

1. Angele S, Lauge A, Fernet M, Moullan N, Beauvais P, Couturier J, Stoppa-Lyonnet D, Hall J (2003) Phenotypic cellular characterization of an ataxia telangiectasia patient carrying a causal homozygous missense mutation. Hum Mutat 21(2): 169-170
2. Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O,Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi OP, Eerola H, Nevanlinna H, Pharoah PD, Easton DF (2008) The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 98(8): 1457-1466 (Pubitemid 351543573)
3. Austen B, Barone G, Reiman A, Byrd PJ, Baker C, Starczynski J, Nobbs MC, Murphy RP, Enright H, Chaila E, Quinn J, Stankovic T, Pratt G, Taylor AM (2008) Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients. Br J Haematol 142(6): 925-933
4. Barone G, Groom A, Reiman A, Srinivasan V, Byrd PJ, Taylor AM (2009) Modeling ATM mutant proteins from missense changes confirms retained kinase activity. Hum Mutat 30(8): 1222-1230
5. Bredemeyer AL, Huang CY, Walker LM, Bassing CH, Sleckman BP (2008) Aberrant V(D)J recombination in ataxia telangiectasia mutated-deficient lymphocytes is dependent on nonhomologous DNA end joining. J Immunol 181(4): 2620-2625
6. Bredemeyer AL, Sharma GG, Huang CY, Helmink BA, Walker LM, Khor KC, Nuskey B, Sullivan KE, Pandita TK, Bassing CH, Sleckman BP (2006) ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 442(7101): 466-470 (Pubitemid 44264797)
7. Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, Scott C, Pupo GM, Dörk T, Bendix R, Kirk J, Tucker K, McCredie MR, Hopper JL, Sambrook J, Mann GJ, Khanna KK (2002) Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 94(3): 205-215 (Pubitemid 34162754)
8. Geoffroy-Perez B, Janin N, Ossian K, Lauge A, Croquette MF, Griscelli C, Debre M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N (2001) Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 93(2): 288-293 (Pubitemid 32574287)
9. Greaves MF, Wiemels J (2003) Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3(9): 639-649 (Pubitemid 37328819)
10. Hewitt SL, Yin B, Ji Y, Chaumeil J, Marszalek K, Tenthorey J, Salvagiotto G, Steinel N, Ramsey LB, Ghysdael J, Farrar MA, Sleckman BP, Schatz DG, Busslinger M, Bassing CH, Skok JA (2009) RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci. Nat Immunol 10(6): 655-664
11. Hiel JA, van Engelen BG, Weemaes CM, Broeks A, Verrips A, ter LH, Vingerhoets HM, van den Heuvel LP, Lammens M, Gabreels FJ, Last JI, Taylor AM (2006) Distal spinal muscular atrophy as a major feature in adult-onset ataxia telangiectasia. Neurology 67(2): 346-349 (Pubitemid 44305433)
12. Huang CY, Sharma GG, Walker LM, Bassing CH, Pandita TK, Sleckman BP (2007) Defects in coding joint formation in vivo in developing ATM-deficient B and T lymphocytes. J Exp Med 204(6): 1371-1381 (Pubitemid 46919875)
13. McConville CM, Stankovic T, Byrd PJ, McGuire GM, Yao QY, Lennox GG, Taylor MR (1996) Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet 59(2): 320-330 (Pubitemid 26266347)
14. Morrell D, Cromartie E, Swift M (1986) Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 77(1): 89-92 (Pubitemid 16077187)
15. Olsen JH, Hahnemann JM, Borresen-Dale AL, Brondum-Nielsen K, Hammarstrom L, Kleinerman R, Kaariainen H, Lonnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice Jr JD, Tucker M (2001) Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst 93(2): 121-127 (Pubitemid 32111989)
16. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR, Rahman N (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38(8): 873-875 (Pubitemid 44141653)
17. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, ARLETT CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268(5218): 1749-1753
18. Spector BD, Filipovich AH, Perry GS, Kersey JH (1982) Epidemiology of cancer in ataxia telangiectasia. In Ataxia Telangiectasia. A Cellular And Molecular Link Between Cancer, Neuropathology And Immune Deficiency Bridges BA, Harnden DG (eds), pp 103-138. John Wiley and Sons: Chichester
19. Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AM (1998) ATM mutations and phenotypes in ataxia-telangiecta-sia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62(2): 334-345 (Pubitemid 28110776)
20. Staples ER, McDermott EM, Reiman A, Byrd PJ, Ritchie S, Taylor AM, Davies EG (2008) Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol 153(2): 214-220 (Pubitemid 351989158)
21. Stewart GS, Last JI, Stankovic T, Haites N, Kidd AM, Byrd PJ, Taylor AM (2001) Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-4G mutations, showing a less severe phenotype. J Biol Chem 276(32): 30133-30141
22. Sutton IJ, Last JI, Ritchie SJ, Harrington HJ, Byrd PJ, Taylor AM (2004) Adult-onset ataxia telangiectasia due to ATM 5762ins137 mutation homozygosity. Ann Neurol 55(6): 891-895 (Pubitemid 38702588)
23. Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325(26): 1831-1836
24. Taylor AM, Byrd PJ (2005) Molecular pathology of ataxia telangiectasia. J Clin Pathol 58(10): 1009-1015 (Pubitemid 41416047)
25. Taylor AM, Metcalfe JA, Thick J, Mak YF (1996) Leukemia and lymphoma in ataxia telangiectasia. Blood 87(2): 423-438 (Pubitemid 26030297)
26. Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, Easton DF (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97(11): 813-822 (Pubitemid 40909124)
27. Vacchio MS, Olaru A, Livak F, Hodes RJ (2007) ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks. Proc Natl Acad Sci USA 104(15): 6323-6328 (Pubitemid 47186093)
28. Verhagen MM, Abdo WF, Willemsen MA, Hogervorst FB, Smeets DF, Hiel JA, Brunt ER, van Rijn MA, Majoor KD, Oldenburg RA, Broeks A, Last JI, van't Veer LJ, Tijssen MA, Dubois AM, Kremer HP, Weemaes CM, Taylor AM, van DM (2009) Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology 73(6): 430-437